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Acetaminophen (N-acetyl para amino phenol, APAP) is a widely used antipyretic and analgesic drug 
responsible for various drug-induced liver injuries. This study evaluated APAP-induced toxicity in isolated 
rat hepatocytes alongside the protective effects of silafibrate and N-acetyl cysteine (NAC). Hepatocytes 
were isolated from male Sprague-Dawley rats by collagenase enzyme perfusion via the portal vein. This 
technique is based on liver perfusion with collagenase after removing calcium ions (Ca2+) with a chelator. 
Cells were treated with different concentrations of APAP, silafibrate, and NAC. Cell death, reactive oxygen 
species (ROS) formation, lipid peroxidation, and mitochondrial depolarisation were measured as toxicity 
markers. ROS formation and lipid peroxidation occurred after APAP administration to rat hepatocytes. 
APAP caused mitochondrial depolarisation in isolated cells. Administration of silafibrate (200 µmol L-1) 
and/or NAC (200 µmol L-1) reduced the ROS formation, lipid peroxidation, and mitochondrial depolarisation 
caused by APAP. Cytotoxicity induced by APAP in rat hepatocytes was mediated by oxidative stress. In 
addition, APAP seemed to target cellular mitochondria during hepatocyte damage. The protective properties 
of silafibrate and/or NAC against APAP-induced hepatic injury may have involved the induction of 
antioxidant enzymes, protection against oxidative stress and inflammatory responses, and alteration in 
cellular glutathione content.
KEY WORDS: drug-induced liver injury (DILI); fibrates; mitochondria; oxidative stress; reactive oxygen 
species (ROS)
Nafisi S, et al. EFFECTS OF SILAFIBRATE AGAINST APAP IN RAT HEPATOCYTES
Arh Hig Rada Toksikol 2014;65:169-178
Acetaminophen (N-acetyl para amino phenol, 
APAP) is a widely used analgesic and antipyretic drug, 
which if applied excessively can cause severe hepatic 
damage or even death in experimental animals and 
individuals (1). At recommended doses, APAP is 
mainly metabolised by sulphation and glucuronidation 
(2). A small proportion of APAP is metabolised 
through cytochrome CYP2E1 and, to a lesser extent, 
CYP1A2 and CYP3A4, which produce the reactive 
metabolite N-acetyl-p-benzoquinoneimine (NAPQI). 
This reactive intermediate is efficiently detoxified by 
conjugation with glutathione (3). However, in 
overdoses, a large amount of APAP is metabolised 
through the P450 family of cytochromes leading to 
GSH depletion by NAPQI conjugation followed by 
the covalent binding of NAPQI to proteins (4). 
Cellular mitochondria seem to be the target for 
acetaminophen-induced hepatotoxicity (5).
Although the precise mechanism of APAP 
hepatotoxicity is not fully understood, some studies 
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(5, 6) have suggested that NAPQI exerts a cytotoxic 
effect through its covalent binding to cytosolic or 
microsomal proteins and membrane components, 
inducing oxidative stress in cells, inhibition of 
mitochondrial respiration, and depletion of cellular 
ATP. Research on acetaminophen-induced 
hepatotoxicity and finding new approaches to prevent 
it is a dynamic field of research due to high incidence 
of hepatotoxicity induced by this drug accidentally or 
in suicidal attempts (6,7).
Silafibrate (ethyl 2-(4-(trimethylsilyl) phenoxy)-
2-methylpropanoate) (Figure 1) is a siliconated 
derivative of the drug clofibrate (8). Fibrates belong 
to the peroxisome proliferator-activated receptor α 
(PPAR-α) drug group, which has been reported to have 
anti-inflammatory effects (9). Furthermore, PPAR 
ligands’ antioxidant and oxidative stress modulating 
properties have been shown in previous studies 
(10,11). It has been reported that the trimethylsilyl 
group in silafibrate (Figure 1) increases the 
anti-inflammatory properties of clofibrate and 
enhances its pharmacological effect on PPAR 
receptors (8). It has also been shown that PPAR 
receptors have a crucial role in preventing APAP-
induced hepatic damage (12). The role of silafibrate, 
as a new and more potent analogue of clofibrate (8) 
against APAP-induced hepatotoxicity in isolated rat 
hepatocytes was evaluated in this study. The protective 
role of N-acetylcysteine (NAC) as a gold standard 
treatment for acetaminophen-induced hepatotoxicity 
(13), was also studied and compared with silafibrate 
in this investigation.
 Cell death, oxidative stress induction (ROS 
formation), lipid peroxidation, and mitochondrial 




Acetaminophen was purchased from Medisca 
Pharmaceutique Incorporation (Montreal, Canada). 
N-acetyl cysteine (NAC) and (4-(2-hydroxyethyl) 
1-piperazine-ethanessulfonic acid (HEPES) were 
obtained from Acros (New Jersey, USA). Albumine 
bovine type was purchased from Roche Diagnostics 
Corporation (Indianapolis USA). Rhodamine 123 and 
Collagenase from Clostridium histolyticum were 
obtained from Sigma Aldrich (St. Louis, MO, USA). 
Trichloroacetic acid (TCA), ethyleneglycol-
bis (ρ-aminoethylether)-N,N,N′,N′-tetra acetic acid 
(EGTA), and Trypan Blue were obtained from Merck 
(Darmstadt, Germany). A siliconised analogue of 
clofibrate, silafibrate, was synthesised in the Chemistry 
and Chemical Engineering Research Center, Tehran, 
Iran. Thiobarbituric acid (TBA) was obtained from 
SERVA (Heidenberg, New York). All salts used for 
preparing buffer solutions were of analytical grade 
and obtained from Merck (Darmstadt, Germany).
Hepatocyte preparation
Male Sprague-Dawley rats (three animals for each 
test, N=15) weighing 250–300 g were housed in plastic 
cages at ambient temperature (25±3 °C). Animals had 
free access to food and water. Collagenase perfusion 
method was used to isolate rat hepatocytes (14). This 
technique is based on liver perfusion with collagenase 
after the removal of calcium ion (Ca2+) with a chelator 
(EGTA 0.5 mol L-1). The liver was perfused with 
different buffer solutions through the portal vein. 
Collagenase-containing buffer solution destructed 
liver interstitial tissue and caused hepatocytes to be 
easily isolated. Isolated hepatocytes (10 mL, 106 cells 
mL-1) were incubated in the Krebs-Henseleit buffer 
(pH 7.4) under an atmosphere of 95 % O2 and 5 % 
CO2, in 50 mL round bottom flasks which were 
continuously rotating in a water bath at 37 °C. For 
more precise details on isolated rat hepatocytes 
preparation, readers are referred to Moldéus et al (15). 
As CYP2E1, the acetaminophen-metabolising enzyme 
expression is low in rat liver (16), we used the enzyme 
induction method by administering β-naphtoflavone 
(40 mg kg-1, i.p., for three consecutive days) (17) to 
accelerate acetaminophen-induced toxicity in rat 
hepatocytes. After this, hepatocytes were isolated and 
used. All animals received humane care and were used 
Nafisi S, et al. EFFECTS OF SILAFIBRATE AGAINST APAP IN RAT HEPATOCYTES
Arh Hig Rada Toksikol 2014;65:169-178
Figure 1 Chemical structure of silafibrate (left) and 
acetaminophen (right)
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according to the criteria outlined in the “Guide for the 
Care and Use of Laboratory Animals” (18), which was 
approved by the local ethic committee in Tabriz 
University of Medical Sciences, Tabriz, Iran.
Different concentrations of acetaminophen were 
added to the cellular media to find the dose response 
of the drug in rat hepatocytes and the LC50 concentration 
(the concentration which leads to 50 % cell death after 
120 min of incubation) for the next experiments.
Cell viability
Trypan blue dye exclusion staining was used to 
assess the percentage of dead cells (19). Hepatocyte 
viability was determined at different time intervals to 
evaluate the effect of acetaminophen on cell viability. 
LC50 dose of the drug was determined and the 
protective effects of silafibrate and NAC against cell 
death induced by acetaminophen were tested. 
Hepatocytes were at least 85 % viable before their use, 
as recommended in previous studies (20-27).
Reactive oxygen species (ROS) formation
To determine the extent of ROS generated during 
acetaminophen metabolism, 2,7-dichlorofluorescein 
diacetate (DCFH-DA; 1.6 µmol L-1) was added to the 
hepatocyte incubate. DCFH-DA was first hydrolysed 
to non-fluorescent DCFH in hepatocytes. DCFH then 
reacted with ROS to form the highly fluorescent 
DCFH. 1 mL (approximately 106 cells) of hepatocyte 
suspension was taken and the fluorescence intensity 
was measured using a Jasco® FP-750 spectrofluorometer 
(Jasco Corporation, Tokyo, Japan) with excitation and 
emission wavelengths of 500 nm and 520 nm, 
respectively (28).
Lipid peroxidation measurement
Hepatocyte lipid peroxidation was determined by 
measuring the amount of thiobarbituric acid reactive 
substances (TBARS) formed during the decomposition 
of lipid hydroperoxides. After treating 1 mL aliquots 
of hepatocyte suspension (106 cells mL-1) with 
trichloroacetic acid (70 % w/v) and boiling the 
supernatant with thiobarbituric acid (0.8 % w/v) for 
20 min, the absorbance of the observed colour was 
determined using an Ultrospec® 2000 UV 
spectrophotometer at 532 nm (Pharmacia Biotech 
Cambridge, England) (29).
Mitochondrial membrane potential
Mitochondrial membrane potential was assessed as 
an indicator of toxicity induced by methimazole or 
N-methylthiourea. The fluorescent dye, rhodamine 123, 
was used as a probe to evaluate the mitochondrial 
membrane potential in rat hepatocytes. Samples 
(1 mL) were taken from the cell suspension at 
scheduled time points, and centrifuged at 1000 g for 
1 min. The cell pellet was then resuspended in 2 mL 
of fresh incubation medium containing 1.5 µmol L-1 
rhodamine 123 and gently shaken in a thermostatic 
water bath at 37 °C for 10 min. Hepatocytes were 
separated by centrifugation (402 g for one min) and 
the amount of rhodamine 123 appearing in the 
incubation medium was measured fluorimeterically 
at 490 nm excitation and 520 nm emission wavelengths 
using a Jasco® FP-750 spectrofluorometer (30).
Statistical analysis
Results are given as mean±SE for at least three 
independent experiments. Statistical analysis was 
performed by one-way analysis of variance (ANOVA) 
followed by a Tukey’s post hoc test. P<0.05 was 
considered as significant difference.
RESULTS
In isolated rat hepatocytes, acetaminophen hardly 
caused cytotoxicity and very high concentrations of 
the drug were needed to induce toxicity (Figure 2). 
Hence, to accelerate the acetaminophen-induced 
toxicity, we used the enzyme-induced hepatocyte 
model. The LC50 of acetaminophen was found to be 
750 µmol L-1 (Figure 2). Different compounds (APAP 
in combination with proposed protective agents such 
as silafibrate and/or NAC) were added to the 
incubation medium, aimed to determine their ability 
to modulate the toxic response of acetaminophen. 
Silafibrate and/or NAC caused no significant toxicity 
in hepatocytes as compared to the control cells when 
administered alone at given concentrations.
Administration of NAC (200 µmol L -1) or 
silafibrate (200 µmol L-1) effectively reduced cell 
death (Figure 3), a significant amount of formed ROS 
(Figure 4), and lipid peroxidation (Figure 5) caused 
by acetaminophen. Acetaminophen also caused 
mitochondrial depolarisation in rat hepatocytes 
(Figure 6) and NAC or silafibrate proved to have a 
preventive role in this regard (Figure 6).
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Figure 2 Dose-response of acetaminophen-induced cytotoxicity in isolated rat hepatocytes.
BNF: β-naphtoflavone
* Indicates the significantly higher cell death than that of control group (p<0.05).
Hepatocytes cell death was not significant in the control group at different time intervals as assessed by trypan blue 
exclusion test.
Figure 3 The protective effect of N-acetyl cysteine (NAC) and silafibrate against acetaminophen-induced cytotoxicity in rat 
hepatocytes.
* Indicates significantly higher cytotoxicity as compared to the control group (p<0.05).
a Indicates significantly lower cytotoxicity as compared to the acetaminophen-treated group (p<0.05)
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DISCUSSION
Drug-induced liver disease is the most common 
cause of acute liver failure, and acetaminophen 
accounts for the bulk of these (6). Incubation of 
enzyme-induced rat hepatocytes with acetaminophen 
caused cell death concentration-dependently. The LC50 
for acetaminophen was 750 µmol L-1. Acetaminophen 
caused ROS formation, lipid peroxidation, and 
mitochondrial depolarisation in isolated rat 
hepatocytes. Administration of NAC and/or silafibrate 
diminished the toxic effects of acetaminophen in rat 
hepatocytes.
In previous studies, it has been shown that 
administration of PPAR ligands such as clofibrate 
diminished acetaminophen-induced hepatotoxicity in 
in vivo models (31). In addition, it has been found that 
PPARs null mice (PPARs -/-) were more susceptible 
to hepatotoxicity induced by acetaminophen (32). 
Furthermore, the protective effects of PPAR ligands 
in in vitro experiments have been shown (33).
However, the mechanism(s) underlying the 
hepatoprotection afforded by peroxisome proliferators 
have yet to be clarified, but the  induction of 
antioxidant enzymes (34), alteration in cellular 
glutathione content (35), and protection against 
oxidative stress and inflammatory responses (36-38) 
are the proposed protective mechanisms. It has been 
found that PPAR ligands have a role in modulating 
oxidative stress and its deleterious consequences in 
different tissues such as liver (39), nervous (40), and 
vascular systems (41). These mechanisms could be 
involved in the protective properties of silafibrate 
against APAP-induced cytotoxicity in freshly-isolated 
rat hepatocytes. Currently there is no data available 
on the direct effect of silafibrate on ROS in biological 
systems. However, the chemical structure of this drug 
and its direct effects on reactive species might also be 
attributed to its protective properties in isolated rat 
hepatocytes. This characteristic might arise from high 
electron-donating nature of trimethylsilyl (TMS) 
group in the drug.
NAC is a standard clinical treatment against APAP-
induced hepatotoxicity (42). It provides protection 
mainly by counteracting oxidative stress (43), and 
scavenging APAP reactive metabolite (44). Moreover, 
it replenishes hepatic glutathione reservoirs as a 
crucial defence barrier against xenobiotics (44).
We found that acetaminophen caused ROS 
formation in isolated rat hepatocytes (Figure 4). Since 
PPARα ligands showed anti-oxidative stress properties 
in previous studies (36, 37, 45), one of the mechanisms 
by which the drug silafibrate may protect rat 
hepatocytes against acetaminophen might be its effect 
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Figure 4 Acetaminophen-induced ROS formation in isolated rat hepatocytes and the effect of NAC and silafibrate 
administration.
*Significantly higher ROS level than control group (p<0.05).
# Significantly lower ROS level than acetaminophen-treated hepatocytes (p<0.05)
174
on alleviating oxidative stress (Figure 4). The effect 
of silafibrate on lipid peroxidation induced by 
acetaminophen could be attributed to its effect on 
reducing the ROS level, which is a major cause of 
lipid peroxidation in cells (46).
It has been shown that oxidative stress is one of 
the major causes of mitochondrial damage (47). A part 
of silafibrate protection against acetaminophen-induced 
cytotoxicity may be due to its effect in preventing 
mitochondrial injury caused by this drug. In the current 
investigation we found that silafibrate as a new and 
more potent analogue of clofibrate (8) showed 
protective effects against APAP-induced cytotoxicity. 
These results might provide new therapeutic strategies 
against APAP-induced hepatotoxicity.
CONCLUSION
Silafibrate as a newly synthesised analogue of 
clofibrate protected rat hepatocytes against 
acetaminophen-induced toxicity. The protective 
effects of silafibrate could be attributed to its role in 
counteracting oxidative stress and/or its consequences 
such as lipid peroxidation and mitochondrial damage. 
The  induction of antioxidant enzymes (34), alteration 
in cellular glutathione content (35), and protection 
against oxidative stress and inflammatory responses 
(36-38) might be involved in the cytoprotective 
properties of silafibrate. On the other hand, the 
duration of study in this in vitro model of isolated rat 
hepatocytes might not be sufficient to observe some 
silafibrate protective properties, such as induction of 
antioxidant enzymes. Future in vivo investigations will 
provide more insights on silafibrate hepatoprotective 
properties.
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Figure 5 Lipid peroxidation caused by acetaminophen (APAP) in isolated rat hepatocytes and the protective role of N-acetyl 
cisteine (NAC) and silafibrate.
*Significantly higher TBARS level than control group (p<0.05).
§ Significantly lower TBARS level than acetaminophen-treated group (p<0.05)
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Sažetak
Citoprotektivni učinci silafibrata, novosintetiziranog silikoniranog derivata klofibrata protiv 
acetaminofenom izazvane toksičnosti u izoliranim hepatocitima štakora
Acetaminofen (N-acetil-para-aminofenol, APAP) često je korišteni antipiretik i analgetik koji može izazvati 
oštećenja jetara. Na modelu izoliranih hepatocita štakora istražili smo toksične učinke APAP-a i protektivne 
učinke silafibrata i N-acetilcisteina (NAC). Hepatociti su izolirani iz mužjaka štakora soja Sprague-Dawley 
perfuzijom jetara i uvođenjem enzima kolagenaze putem portalne vene. Ta se tehnika zasniva na perfuziji 
jetara kolagenazom nakon uklanjanja kalcijevih iona (Ca2+) kelatorom. Stanice su tretirane različitim 
koncentracijama APAP-a, silafibrata i NAC-a. Kao markeri toksičnosti mjereni su smrt stanica, stvaranje 
reaktivnih kisikovih vrsta (ROS), lipidna peroksidacija i depolarizacija mitohondrija. Primjena APAP-a u 
štakora izazvala je stvaranje ROS-ova i lipidnu peroksidaciju. APAP je uzrokovao depolarizaciju 
mitohondrija u izoliranim stanicama. Primjena silafibrata (200 µmol L-1) i/ili NAC-a (200 µmol L-1) smanjila 
je stvaranje ROS-a, lipidnu peroksidaciju i depolarizaciju mitohondrija uzrokovanu APAP-om. Utvrdili 
smo da je citotoksičnost APAP-a posredovana oksidativnim stresom. Nadalje, čini se da su mitohondriji 
ciljni stanični organeli za oštećenja hepatocita izazvanih APAP-om. Moguće je da su protektivna svojstva 
silafibrata i/ili NAC-a protiv APAP-om induciranog oštećenja jetara uključivala i indukciju antioksidacijskih 
enzima, zaštitu od oksidativnog stresa i upalnih odgovora te promjenu razine staničnoga glutationa.
KLJUČNE RIJEČI: fibrati; mitohondriji; oksidativni stres; oštećenje jetara izazvano lijekom; 
reaktivne kisikove vrste (ROS)
